Parashore pear slices contaminated with elevated lead and cadmium
Parashore Pear Slices in Juice, 15 oz, are being recalled because the product is contaminated with elevated lead and cadmium. 8,160 units are affected.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA Class I recall, which the rubric floors at Severe; no illness is reported in the source, so it does not escalate to Critical.
Plain-English summary
Parashore Pear Slices in Juice, 15 oz (425 g), UPC 704817164237, are being recalled. The action covers 8,160 units.
The stated reason is that the product is contaminated with elevated lead and cadmium. The FDA classified the action as Class I, its most serious classification.
Affected product carries lot 3700/01172 6122J, produced 02/19/2024, with a best by date of 2/19/2027. Distribution was in California.
Consumers who have the product should not eat it and should return it to the place of purchase. Anyone who has eaten it and feels unwell should seek medical advice.
The recalled product
- Product
- Parashore Pear Slices in Juice, 15 oz. (425 g), UPC#704817164237
- Manufacturer
- W.W. Industrial Group, Inc.
- Category
- Food — Canned fruit
- Affected units
- 8,160
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot 3700/01172 6122J Prod: 02/19/2024
- Best by 2/19/2027
Distribution
Distributed in 1 state:
Related recalls
Same hazard · lead
See all →- HighDragonfly Thai ginger powder may be contaminated with lead
FDA (Food) · 2026-06-17
- HighSpice powder recalled after lead level exceeded the New York standard
FDA (Food) · 2026-04-29
- CriticalRheumacare capsules recalled after the product was found to contain lead
FDA (Drugs) · 2026-02-11
- HighCinnamon powder recalled over potential contamination with lead
FDA (Food) · 2026-02-11
- HighGround cinnamon recalled over elevated levels of lead
FDA (Drugs) · 2026-01-21